1. Home
  2. PRME vs HYLN Comparison

PRME vs HYLN Comparison

Compare PRME & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • HYLN
  • Stock Information
  • Founded
  • PRME 2019
  • HYLN 2018
  • Country
  • PRME United States
  • HYLN United States
  • Employees
  • PRME N/A
  • HYLN N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • HYLN Construction/Ag Equipment/Trucks
  • Sector
  • PRME Health Care
  • HYLN Consumer Discretionary
  • Exchange
  • PRME Nasdaq
  • HYLN Nasdaq
  • Market Cap
  • PRME 379.1M
  • HYLN 453.4M
  • IPO Year
  • PRME 2022
  • HYLN N/A
  • Fundamental
  • Price
  • PRME $2.97
  • HYLN $1.91
  • Analyst Decision
  • PRME Strong Buy
  • HYLN Hold
  • Analyst Count
  • PRME 9
  • HYLN 1
  • Target Price
  • PRME $13.13
  • HYLN $2.00
  • AVG Volume (30 Days)
  • PRME 1.0M
  • HYLN 895.4K
  • Earning Date
  • PRME 03-04-2025
  • HYLN 02-25-2025
  • Dividend Yield
  • PRME N/A
  • HYLN N/A
  • EPS Growth
  • PRME N/A
  • HYLN N/A
  • EPS
  • PRME N/A
  • HYLN N/A
  • Revenue
  • PRME $800,000.00
  • HYLN N/A
  • Revenue This Year
  • PRME N/A
  • HYLN N/A
  • Revenue Next Year
  • PRME $477.62
  • HYLN $4,220.00
  • P/E Ratio
  • PRME N/A
  • HYLN N/A
  • Revenue Growth
  • PRME N/A
  • HYLN N/A
  • 52 Week Low
  • PRME $2.25
  • HYLN $1.20
  • 52 Week High
  • PRME $9.77
  • HYLN $4.10
  • Technical
  • Relative Strength Index (RSI)
  • PRME 53.25
  • HYLN 32.77
  • Support Level
  • PRME $2.25
  • HYLN $1.95
  • Resistance Level
  • PRME $3.36
  • HYLN $2.20
  • Average True Range (ATR)
  • PRME 0.23
  • HYLN 0.13
  • MACD
  • PRME 0.07
  • HYLN -0.00
  • Stochastic Oscillator
  • PRME 64.41
  • HYLN 0.00

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it is also focused on mobile applications, including vehicles and marine technologies. The Company aims to offer innovative, yet practical solutions that contribute positively to the environment in the energy economy.

Share on Social Networks: